nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CYP3A4—Fingolimod—multiple sclerosis	0.0582	0.208	CbGbCtD
Acetazolamide—SLC22A6—Methotrexate—multiple sclerosis	0.0427	0.153	CbGbCtD
Acetazolamide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0375	0.134	CbGbCtD
Acetazolamide—CYP3A4—Triamcinolone—multiple sclerosis	0.0284	0.102	CbGbCtD
Acetazolamide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0273	0.0979	CbGbCtD
Acetazolamide—CYP3A4—Betamethasone—multiple sclerosis	0.0244	0.0873	CbGbCtD
Acetazolamide—CYP3A4—Prednisolone—multiple sclerosis	0.024	0.0861	CbGbCtD
Acetazolamide—CYP3A4—Prednisone—multiple sclerosis	0.0227	0.0813	CbGbCtD
Acetazolamide—AQP1—Passive transport by Aquaporins—AQP4—multiple sclerosis	0.0215	0.202	CbGpPWpGaD
Acetazolamide—CYP3A4—Dexamethasone—multiple sclerosis	0.0142	0.0508	CbGbCtD
Acetazolamide—AQP1—retina—multiple sclerosis	0.0102	0.0572	CbGeAlD
Acetazolamide—CA1—nerve—multiple sclerosis	0.0101	0.0569	CbGeAlD
Acetazolamide—CA4—nerve—multiple sclerosis	0.00789	0.0444	CbGeAlD
Acetazolamide—AQP1—Vasopressin regulates renal water homeostasis via Aquaporins—AQP4—multiple sclerosis	0.00773	0.0729	CbGpPWpGaD
Acetazolamide—AQP1—medulla oblongata—multiple sclerosis	0.00734	0.0414	CbGeAlD
Acetazolamide—AQP1—Aquaporin-mediated transport—AQP4—multiple sclerosis	0.00675	0.0636	CbGpPWpGaD
Acetazolamide—AQP1—midbrain—multiple sclerosis	0.00671	0.0378	CbGeAlD
Acetazolamide—AQP1—spinal cord—multiple sclerosis	0.00655	0.0369	CbGeAlD
Acetazolamide—AQP1—nervous system—multiple sclerosis	0.00552	0.0311	CbGeAlD
Acetazolamide—CA7—midbrain—multiple sclerosis	0.00537	0.0302	CbGeAlD
Acetazolamide—AQP1—central nervous system—multiple sclerosis	0.00531	0.0299	CbGeAlD
Acetazolamide—AQP1—cerebellum—multiple sclerosis	0.00519	0.0293	CbGeAlD
Acetazolamide—CA14—medulla oblongata—multiple sclerosis	0.00489	0.0276	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—MBP—multiple sclerosis	0.00455	0.0429	CbGpPWpGaD
Acetazolamide—CA14—midbrain—multiple sclerosis	0.00447	0.0252	CbGeAlD
Acetazolamide—CA14—spinal cord—multiple sclerosis	0.00436	0.0246	CbGeAlD
Acetazolamide—AQP1—brain—multiple sclerosis	0.00422	0.0238	CbGeAlD
Acetazolamide—CA7—cerebellum—multiple sclerosis	0.00415	0.0234	CbGeAlD
Acetazolamide—CA3—nervous system—multiple sclerosis	0.00405	0.0228	CbGeAlD
Acetazolamide—CA3—central nervous system—multiple sclerosis	0.0039	0.0219	CbGeAlD
Acetazolamide—CA9—cerebellum—multiple sclerosis	0.00365	0.0205	CbGeAlD
Acetazolamide—CA14—cerebellum—multiple sclerosis	0.00346	0.0195	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—AQP4—multiple sclerosis	0.00345	0.0325	CbGpPWpGaD
Acetazolamide—CA4—brainstem—multiple sclerosis	0.00339	0.0191	CbGeAlD
Acetazolamide—CA7—brain—multiple sclerosis	0.00337	0.019	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.00322	0.00737	CcSEcCtD
Acetazolamide—CA3—brain—multiple sclerosis	0.00309	0.0174	CbGeAlD
Acetazolamide—Tingling sensation—Methylprednisolone—multiple sclerosis	0.00303	0.00694	CcSEcCtD
Acetazolamide—Glycosuria—Triamcinolone—multiple sclerosis	0.00302	0.0069	CcSEcCtD
Acetazolamide—Glycosuria—Methylprednisolone—multiple sclerosis	0.00301	0.00688	CcSEcCtD
Acetazolamide—CA12—nervous system—multiple sclerosis	0.00287	0.0161	CbGeAlD
Acetazolamide—CA14—brain—multiple sclerosis	0.00281	0.0158	CbGeAlD
Acetazolamide—CA2—brainstem—multiple sclerosis	0.00281	0.0158	CbGeAlD
Acetazolamide—Paraesthesia—Fingolimod—multiple sclerosis	0.00278	0.00637	CcSEcCtD
Acetazolamide—CA12—central nervous system—multiple sclerosis	0.00276	0.0155	CbGeAlD
Acetazolamide—Tingling sensation—Betamethasone—multiple sclerosis	0.00276	0.00631	CcSEcCtD
Acetazolamide—Tingling sensation—Dexamethasone—multiple sclerosis	0.00276	0.00631	CcSEcCtD
Acetazolamide—Glycosuria—Betamethasone—multiple sclerosis	0.00274	0.00626	CcSEcCtD
Acetazolamide—Glycosuria—Dexamethasone—multiple sclerosis	0.00274	0.00626	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00273	0.00625	CcSEcCtD
Acetazolamide—CA2—retina—multiple sclerosis	0.00271	0.0153	CbGeAlD
Acetazolamide—CA1—spinal cord—multiple sclerosis	0.00269	0.0152	CbGeAlD
Acetazolamide—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00268	0.00612	CcSEcCtD
Acetazolamide—Fatigue—Fingolimod—multiple sclerosis	0.00267	0.00612	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.00262	0.00599	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Cladribine—multiple sclerosis	0.00261	0.00596	CcSEcCtD
Acetazolamide—CA5B—nervous system—multiple sclerosis	0.00257	0.0145	CbGeAlD
Acetazolamide—CA5B—central nervous system—multiple sclerosis	0.00247	0.0139	CbGeAlD
Acetazolamide—SLC22A6—brain—multiple sclerosis	0.00245	0.0138	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.00243	0.00556	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—CCR2—multiple sclerosis	0.00239	0.0225	CbGpPWpGaD
Acetazolamide—Glycosuria—Prednisone—multiple sclerosis	0.00238	0.00545	CcSEcCtD
Acetazolamide—CA4—medulla oblongata—multiple sclerosis	0.00236	0.0133	CbGeAlD
Acetazolamide—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.00236	0.0054	CcSEcCtD
Acetazolamide—Erythema multiforme—Cladribine—multiple sclerosis	0.00234	0.00535	CcSEcCtD
Acetazolamide—CA1—nervous system—multiple sclerosis	0.00227	0.0128	CbGeAlD
Acetazolamide—Asthenia—Fingolimod—multiple sclerosis	0.00222	0.00509	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00222	0.00508	CcSEcCtD
Acetazolamide—CA12—brain—multiple sclerosis	0.00219	0.0123	CbGeAlD
Acetazolamide—CA1—central nervous system—multiple sclerosis	0.00219	0.0123	CbGeAlD
Acetazolamide—CA4—midbrain—multiple sclerosis	0.00216	0.0122	CbGeAlD
Acetazolamide—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.00214	0.00489	CcSEcCtD
Acetazolamide—Diarrhoea—Fingolimod—multiple sclerosis	0.00212	0.00485	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00212	0.00485	CcSEcCtD
Acetazolamide—CA4—spinal cord—multiple sclerosis	0.00211	0.0119	CbGeAlD
Acetazolamide—Agranulocytosis—Azathioprine—multiple sclerosis	0.00209	0.00478	CcSEcCtD
Acetazolamide—Dizziness—Fingolimod—multiple sclerosis	0.00205	0.00469	CcSEcCtD
Acetazolamide—Ill-defined disorder—Cladribine—multiple sclerosis	0.002	0.00457	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.00199	0.00456	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—CXCL10—multiple sclerosis	0.00199	0.0187	CbGpPWpGaD
Acetazolamide—CA5B—brain—multiple sclerosis	0.00196	0.0111	CbGeAlD
Acetazolamide—CA2—medulla oblongata—multiple sclerosis	0.00196	0.011	CbGeAlD
Acetazolamide—Headache—Fingolimod—multiple sclerosis	0.00194	0.00444	CcSEcCtD
Acetazolamide—Malaise—Cladribine—multiple sclerosis	0.00194	0.00444	CcSEcCtD
Acetazolamide—Erythema multiforme—Azathioprine—multiple sclerosis	0.0019	0.00435	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00183	0.00419	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00183	0.00418	CcSEcCtD
Acetazolamide—Discomfort—Cladribine—multiple sclerosis	0.00181	0.00414	CcSEcCtD
Acetazolamide—Drowsiness—Mitoxantrone—multiple sclerosis	0.00181	0.00414	CcSEcCtD
Acetazolamide—CA2—midbrain—multiple sclerosis	0.00179	0.0101	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—BDNF—multiple sclerosis	0.00178	0.0168	CbGpPWpGaD
Acetazolamide—CA4—nervous system—multiple sclerosis	0.00177	0.01	CbGeAlD
Acetazolamide—Confusional state—Cladribine—multiple sclerosis	0.00177	0.00405	CcSEcCtD
Acetazolamide—CA2—spinal cord—multiple sclerosis	0.00175	0.00984	CbGeAlD
Acetazolamide—CA1—brain—multiple sclerosis	0.00174	0.00978	CbGeAlD
Acetazolamide—Haematuria—Mitoxantrone—multiple sclerosis	0.00173	0.00395	CcSEcCtD
Acetazolamide—Thrombocytopenia—Cladribine—multiple sclerosis	0.00172	0.00394	CcSEcCtD
Acetazolamide—CA4—central nervous system—multiple sclerosis	0.00171	0.00962	CbGeAlD
Acetazolamide—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00169	0.00387	CcSEcCtD
Acetazolamide—Irritability—Methylprednisolone—multiple sclerosis	0.00169	0.00386	CcSEcCtD
Acetazolamide—CA4—cerebellum—multiple sclerosis	0.00167	0.00941	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00166	0.0038	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00166	0.0038	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—IL4—multiple sclerosis	0.00166	0.0156	CbGpPWpGaD
Acetazolamide—Ill-defined disorder—Azathioprine—multiple sclerosis	0.00162	0.00372	CcSEcCtD
Acetazolamide—Malaise—Azathioprine—multiple sclerosis	0.00158	0.00361	CcSEcCtD
Acetazolamide—Paraesthesia—Cladribine—multiple sclerosis	0.00158	0.00361	CcSEcCtD
Acetazolamide—Melaena—Methotrexate—multiple sclerosis	0.00158	0.00361	CcSEcCtD
Acetazolamide—Leukopenia—Azathioprine—multiple sclerosis	0.00157	0.00359	CcSEcCtD
Acetazolamide—Somnolence—Cladribine—multiple sclerosis	0.00156	0.00358	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00155	0.0147	CbGpPWpGaD
Acetazolamide—Irritability—Betamethasone—multiple sclerosis	0.00154	0.00351	CcSEcCtD
Acetazolamide—Irritability—Dexamethasone—multiple sclerosis	0.00154	0.00351	CcSEcCtD
Acetazolamide—Decreased appetite—Cladribine—multiple sclerosis	0.00153	0.0035	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00152	0.00347	CcSEcCtD
Acetazolamide—Fatigue—Cladribine—multiple sclerosis	0.00152	0.00347	CcSEcCtD
Acetazolamide—Aplastic anaemia—Methotrexate—multiple sclerosis	0.00151	0.00347	CcSEcCtD
Acetazolamide—Discomfort—Azathioprine—multiple sclerosis	0.00147	0.00337	CcSEcCtD
Acetazolamide—CA2—nervous system—multiple sclerosis	0.00147	0.00829	CbGeAlD
Acetazolamide—Hypokalaemia—Betamethasone—multiple sclerosis	0.00146	0.00335	CcSEcCtD
Acetazolamide—Hypokalaemia—Dexamethasone—multiple sclerosis	0.00146	0.00335	CcSEcCtD
Acetazolamide—Urine output increased—Methotrexate—multiple sclerosis	0.00146	0.00334	CcSEcCtD
Acetazolamide—Feeling abnormal—Cladribine—multiple sclerosis	0.00145	0.00331	CcSEcCtD
Acetazolamide—CA2—central nervous system—multiple sclerosis	0.00142	0.00798	CbGeAlD
Acetazolamide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.0014	0.0032	CcSEcCtD
Acetazolamide—Urticaria—Cladribine—multiple sclerosis	0.0014	0.00319	CcSEcCtD
Acetazolamide—Body temperature increased—Cladribine—multiple sclerosis	0.00139	0.00318	CcSEcCtD
Acetazolamide—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00139	0.00317	CcSEcCtD
Acetazolamide—CA2—cerebellum—multiple sclerosis	0.00138	0.0078	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—TLR4—multiple sclerosis	0.00137	0.0129	CbGpPWpGaD
Acetazolamide—CA4—brain—multiple sclerosis	0.00136	0.00764	CbGeAlD
Acetazolamide—Irritability—Prednisone—multiple sclerosis	0.00134	0.00306	CcSEcCtD
Acetazolamide—Polyuria—Methotrexate—multiple sclerosis	0.00133	0.00305	CcSEcCtD
Acetazolamide—Photosensitivity—Methotrexate—multiple sclerosis	0.00133	0.00305	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—ICAM1—multiple sclerosis	0.00132	0.0124	CbGpPWpGaD
Acetazolamide—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00131	0.00301	CcSEcCtD
Acetazolamide—Hepatic failure—Methotrexate—multiple sclerosis	0.0013	0.00298	CcSEcCtD
Acetazolamide—Malaise—Mitoxantrone—multiple sclerosis	0.00128	0.00292	CcSEcCtD
Acetazolamide—Hypokalaemia—Prednisone—multiple sclerosis	0.00128	0.00292	CcSEcCtD
Acetazolamide—Leukopenia—Mitoxantrone—multiple sclerosis	0.00127	0.0029	CcSEcCtD
Acetazolamide—Asthenia—Cladribine—multiple sclerosis	0.00126	0.00289	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00123	0.00282	CcSEcCtD
Acetazolamide—Convulsion—Mitoxantrone—multiple sclerosis	0.00123	0.00281	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.00121	0.00277	CcSEcCtD
Acetazolamide—Diarrhoea—Cladribine—multiple sclerosis	0.0012	0.00275	CcSEcCtD
Acetazolamide—Discomfort—Mitoxantrone—multiple sclerosis	0.00119	0.00272	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00118	0.0111	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—CCL2—multiple sclerosis	0.00118	0.0111	CbGpPWpGaD
Acetazolamide—Feeling abnormal—Azathioprine—multiple sclerosis	0.00118	0.00269	CcSEcCtD
Acetazolamide—Confusional state—Mitoxantrone—multiple sclerosis	0.00116	0.00267	CcSEcCtD
Acetazolamide—Dizziness—Cladribine—multiple sclerosis	0.00116	0.00266	CcSEcCtD
Acetazolamide—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00116	0.00264	CcSEcCtD
Acetazolamide—Shock—Mitoxantrone—multiple sclerosis	0.00114	0.0026	CcSEcCtD
Acetazolamide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00113	0.00259	CcSEcCtD
Acetazolamide—Body temperature increased—Azathioprine—multiple sclerosis	0.00113	0.00258	CcSEcCtD
Acetazolamide—CA2—brain—multiple sclerosis	0.00112	0.00634	CbGeAlD
Acetazolamide—Irritability—Methotrexate—multiple sclerosis	0.00112	0.00256	CcSEcCtD
Acetazolamide—Vomiting—Cladribine—multiple sclerosis	0.00112	0.00256	CcSEcCtD
Acetazolamide—Ataxia—Methotrexate—multiple sclerosis	0.0011	0.00252	CcSEcCtD
Acetazolamide—Headache—Cladribine—multiple sclerosis	0.0011	0.00252	CcSEcCtD
Acetazolamide—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00108	0.00247	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00105	0.00241	CcSEcCtD
Acetazolamide—Malaise—Prednisolone—multiple sclerosis	0.00105	0.0024	CcSEcCtD
Acetazolamide—Dysgeusia—Triamcinolone—multiple sclerosis	0.00105	0.00239	CcSEcCtD
Acetazolamide—Nausea—Cladribine—multiple sclerosis	0.00104	0.00239	CcSEcCtD
Acetazolamide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00104	0.00237	CcSEcCtD
Acetazolamide—Somnolence—Mitoxantrone—multiple sclerosis	0.00103	0.00235	CcSEcCtD
Acetazolamide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00102	0.00233	CcSEcCtD
Acetazolamide—Convulsion—Prednisolone—multiple sclerosis	0.00101	0.0023	CcSEcCtD
Acetazolamide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.001	0.0023	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—IFNG—multiple sclerosis	0.001	0.00944	CbGpPWpGaD
Acetazolamide—Fatigue—Mitoxantrone—multiple sclerosis	0.000996	0.00228	CcSEcCtD
Acetazolamide—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000991	0.00227	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000989	0.00226	CcSEcCtD
Acetazolamide—Diarrhoea—Azathioprine—multiple sclerosis	0.000978	0.00224	CcSEcCtD
Acetazolamide—Discomfort—Prednisolone—multiple sclerosis	0.000977	0.00224	CcSEcCtD
Acetazolamide—Malaise—Triamcinolone—multiple sclerosis	0.000963	0.0022	CcSEcCtD
Acetazolamide—Malaise—Methylprednisolone—multiple sclerosis	0.000961	0.0022	CcSEcCtD
Acetazolamide—AQP1—Metabolism—SRM—multiple sclerosis	0.000961	0.00906	CbGpPWpGaD
Acetazolamide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000952	0.00218	CcSEcCtD
Acetazolamide—CYP3A4—nervous system—multiple sclerosis	0.000949	0.00535	CbGeAlD
Acetazolamide—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000948	0.00217	CcSEcCtD
Acetazolamide—Dizziness—Azathioprine—multiple sclerosis	0.000945	0.00216	CcSEcCtD
Acetazolamide—Shock—Prednisolone—multiple sclerosis	0.000933	0.00213	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000932	0.00878	CbGpPWpGaD
Acetazolamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000929	0.00876	CbGpPWpGaD
Acetazolamide—Convulsion—Triamcinolone—multiple sclerosis	0.000925	0.00212	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000924	0.00211	CcSEcCtD
Acetazolamide—Convulsion—Methylprednisolone—multiple sclerosis	0.000923	0.00211	CcSEcCtD
Acetazolamide—Urticaria—Mitoxantrone—multiple sclerosis	0.000918	0.0021	CcSEcCtD
Acetazolamide—CYP3A4—central nervous system—multiple sclerosis	0.000914	0.00515	CbGeAlD
Acetazolamide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000913	0.00209	CcSEcCtD
Acetazolamide—Vomiting—Azathioprine—multiple sclerosis	0.000909	0.00208	CcSEcCtD
Acetazolamide—Drowsiness—Methotrexate—multiple sclerosis	0.000903	0.00206	CcSEcCtD
Acetazolamide—Flushing—Prednisone—multiple sclerosis	0.0009	0.00206	CcSEcCtD
Acetazolamide—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000899	0.00206	CcSEcCtD
Acetazolamide—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000899	0.00206	CcSEcCtD
Acetazolamide—Discomfort—Triamcinolone—multiple sclerosis	0.000898	0.00206	CcSEcCtD
Acetazolamide—Discomfort—Methylprednisolone—multiple sclerosis	0.000896	0.00205	CcSEcCtD
Acetazolamide—Headache—Azathioprine—multiple sclerosis	0.000895	0.00205	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000895	0.00205	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—IL1B—multiple sclerosis	0.000893	0.00842	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—IL2—multiple sclerosis	0.00089	0.00839	CbGpPWpGaD
Acetazolamide—Confusional state—Methylprednisolone—multiple sclerosis	0.000877	0.00201	CcSEcCtD
Acetazolamide—Malaise—Betamethasone—multiple sclerosis	0.000874	0.002	CcSEcCtD
Acetazolamide—Malaise—Dexamethasone—multiple sclerosis	0.000874	0.002	CcSEcCtD
Acetazolamide—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000872	0.00199	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00087	0.00199	CcSEcCtD
Acetazolamide—Haematuria—Methotrexate—multiple sclerosis	0.000861	0.00197	CcSEcCtD
Acetazolamide—Shock—Triamcinolone—multiple sclerosis	0.000858	0.00196	CcSEcCtD
Acetazolamide—Shock—Methylprednisolone—multiple sclerosis	0.000856	0.00196	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000854	0.00195	CcSEcCtD
Acetazolamide—Paraesthesia—Prednisolone—multiple sclerosis	0.000851	0.00195	CcSEcCtD
Acetazolamide—Nausea—Azathioprine—multiple sclerosis	0.000849	0.00194	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—MMP9—multiple sclerosis	0.000842	0.00794	CbGpPWpGaD
Acetazolamide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000842	0.00193	CcSEcCtD
Acetazolamide—Convulsion—Dexamethasone—multiple sclerosis	0.00084	0.00192	CcSEcCtD
Acetazolamide—Convulsion—Betamethasone—multiple sclerosis	0.00084	0.00192	CcSEcCtD
Acetazolamide—CA3—Metabolism—SRM—multiple sclerosis	0.000833	0.00785	CbGpPWpGaD
Acetazolamide—Asthenia—Mitoxantrone—multiple sclerosis	0.000829	0.0019	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000823	0.00776	CbGpPWpGaD
Acetazolamide—Discomfort—Betamethasone—multiple sclerosis	0.000815	0.00186	CcSEcCtD
Acetazolamide—Discomfort—Dexamethasone—multiple sclerosis	0.000815	0.00186	CcSEcCtD
Acetazolamide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000791	0.00181	CcSEcCtD
Acetazolamide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000791	0.00181	CcSEcCtD
Acetazolamide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000791	0.00181	CcSEcCtD
Acetazolamide—Ill-defined disorder—Prednisone—multiple sclerosis	0.000783	0.00179	CcSEcCtD
Acetazolamide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000783	0.00179	CcSEcCtD
Acetazolamide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000781	0.00179	CcSEcCtD
Acetazolamide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000781	0.00179	CcSEcCtD
Acetazolamide—Shock—Dexamethasone—multiple sclerosis	0.000778	0.00178	CcSEcCtD
Acetazolamide—Shock—Betamethasone—multiple sclerosis	0.000778	0.00178	CcSEcCtD
Acetazolamide—Agitation—Prednisone—multiple sclerosis	0.000776	0.00177	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000774	0.00177	CcSEcCtD
Acetazolamide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000774	0.00177	CcSEcCtD
Acetazolamide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000767	0.00176	CcSEcCtD
Acetazolamide—Erythema multiforme—Methotrexate—multiple sclerosis	0.000766	0.00175	CcSEcCtD
Acetazolamide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000766	0.00175	CcSEcCtD
Acetazolamide—Malaise—Prednisone—multiple sclerosis	0.000761	0.00174	CcSEcCtD
Acetazolamide—Tinnitus—Methotrexate—multiple sclerosis	0.000755	0.00173	CcSEcCtD
Acetazolamide—Urticaria—Prednisolone—multiple sclerosis	0.000753	0.00172	CcSEcCtD
Acetazolamide—Fatigue—Triamcinolone—multiple sclerosis	0.000752	0.00172	CcSEcCtD
Acetazolamide—Fatigue—Methylprednisolone—multiple sclerosis	0.00075	0.00172	CcSEcCtD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00074	0.00697	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00074	0.00697	CbGpPWpGaD
Acetazolamide—Vomiting—Mitoxantrone—multiple sclerosis	0.000735	0.00168	CcSEcCtD
Acetazolamide—Convulsion—Prednisone—multiple sclerosis	0.000731	0.00167	CcSEcCtD
Acetazolamide—Headache—Mitoxantrone—multiple sclerosis	0.000724	0.00166	CcSEcCtD
Acetazolamide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000718	0.00164	CcSEcCtD
Acetazolamide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000717	0.00164	CcSEcCtD
Acetazolamide—Paraesthesia—Dexamethasone—multiple sclerosis	0.00071	0.00162	CcSEcCtD
Acetazolamide—Paraesthesia—Betamethasone—multiple sclerosis	0.00071	0.00162	CcSEcCtD
Acetazolamide—Discomfort—Prednisone—multiple sclerosis	0.00071	0.00162	CcSEcCtD
Acetazolamide—Dyspepsia—Betamethasone—multiple sclerosis	0.000696	0.00159	CcSEcCtD
Acetazolamide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000696	0.00159	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—MYC—multiple sclerosis	0.000696	0.00656	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000694	0.00654	CbGpPWpGaD
Acetazolamide—Urticaria—Triamcinolone—multiple sclerosis	0.000692	0.00158	CcSEcCtD
Acetazolamide—Urticaria—Methylprednisolone—multiple sclerosis	0.000691	0.00158	CcSEcCtD
Acetazolamide—Dysgeusia—Methotrexate—multiple sclerosis	0.000691	0.00158	CcSEcCtD
Acetazolamide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000689	0.00158	CcSEcCtD
Acetazolamide—Anaphylactic shock—Prednisone—multiple sclerosis	0.000689	0.00158	CcSEcCtD
Acetazolamide—Decreased appetite—Betamethasone—multiple sclerosis	0.000688	0.00157	CcSEcCtD
Acetazolamide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000688	0.00157	CcSEcCtD
Acetazolamide—Nausea—Mitoxantrone—multiple sclerosis	0.000686	0.00157	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000683	0.00156	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000683	0.00156	CcSEcCtD
Acetazolamide—Fatigue—Dexamethasone—multiple sclerosis	0.000682	0.00156	CcSEcCtD
Acetazolamide—Fatigue—Betamethasone—multiple sclerosis	0.000682	0.00156	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—MAPK1—multiple sclerosis	0.000681	0.00642	CbGpPWpGaD
Acetazolamide—Shock—Prednisone—multiple sclerosis	0.000678	0.00155	CcSEcCtD
Acetazolamide—AQP1—Metabolism—CYP24A1—multiple sclerosis	0.000677	0.00638	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CYP27B1—multiple sclerosis	0.000677	0.00638	CbGpPWpGaD
Acetazolamide—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000655	0.00617	CbGpPWpGaD
Acetazolamide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000654	0.0015	CcSEcCtD
Acetazolamide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000652	0.00149	CcSEcCtD
Acetazolamide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000652	0.00149	CcSEcCtD
Acetazolamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000649	0.00612	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—TNF—multiple sclerosis	0.000648	0.00611	CbGpPWpGaD
Acetazolamide—Malaise—Methotrexate—multiple sclerosis	0.000636	0.00146	CcSEcCtD
Acetazolamide—Leukopenia—Methotrexate—multiple sclerosis	0.000631	0.00144	CcSEcCtD
Acetazolamide—Urticaria—Dexamethasone—multiple sclerosis	0.000628	0.00144	CcSEcCtD
Acetazolamide—Urticaria—Betamethasone—multiple sclerosis	0.000628	0.00144	CcSEcCtD
Acetazolamide—Dizziness—Prednisolone—multiple sclerosis	0.000627	0.00143	CcSEcCtD
Acetazolamide—Asthenia—Triamcinolone—multiple sclerosis	0.000625	0.00143	CcSEcCtD
Acetazolamide—Body temperature increased—Betamethasone—multiple sclerosis	0.000625	0.00143	CcSEcCtD
Acetazolamide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000625	0.00143	CcSEcCtD
Acetazolamide—Asthenia—Methylprednisolone—multiple sclerosis	0.000624	0.00143	CcSEcCtD
Acetazolamide—AQP1—Metabolism—GPC5—multiple sclerosis	0.000619	0.00584	CbGpPWpGaD
Acetazolamide—Paraesthesia—Prednisone—multiple sclerosis	0.000618	0.00142	CcSEcCtD
Acetazolamide—Convulsion—Methotrexate—multiple sclerosis	0.000611	0.0014	CcSEcCtD
Acetazolamide—Dyspepsia—Prednisone—multiple sclerosis	0.000606	0.00139	CcSEcCtD
Acetazolamide—Decreased appetite—Prednisone—multiple sclerosis	0.000599	0.00137	CcSEcCtD
Acetazolamide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000595	0.00136	CcSEcCtD
Acetazolamide—Fatigue—Prednisone—multiple sclerosis	0.000594	0.00136	CcSEcCtD
Acetazolamide—Headache—Prednisolone—multiple sclerosis	0.000594	0.00136	CcSEcCtD
Acetazolamide—Discomfort—Methotrexate—multiple sclerosis	0.000593	0.00136	CcSEcCtD
Acetazolamide—CA3—Metabolism—CYP27B1—multiple sclerosis	0.000587	0.00553	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CYP24A1—multiple sclerosis	0.000587	0.00553	CbGpPWpGaD
Acetazolamide—Confusional state—Methotrexate—multiple sclerosis	0.00058	0.00133	CcSEcCtD
Acetazolamide—Dizziness—Triamcinolone—multiple sclerosis	0.000576	0.00132	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000576	0.00132	CcSEcCtD
Acetazolamide—Dizziness—Methylprednisolone—multiple sclerosis	0.000575	0.00132	CcSEcCtD
Acetazolamide—Feeling abnormal—Prednisone—multiple sclerosis	0.000568	0.0013	CcSEcCtD
Acetazolamide—Asthenia—Dexamethasone—multiple sclerosis	0.000567	0.0013	CcSEcCtD
Acetazolamide—Asthenia—Betamethasone—multiple sclerosis	0.000567	0.0013	CcSEcCtD
Acetazolamide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000564	0.00129	CcSEcCtD
Acetazolamide—Nausea—Prednisolone—multiple sclerosis	0.000563	0.00129	CcSEcCtD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000557	0.00525	CbGpPWpGaD
Acetazolamide—Vomiting—Triamcinolone—multiple sclerosis	0.000554	0.00127	CcSEcCtD
Acetazolamide—Vomiting—Methylprednisolone—multiple sclerosis	0.000553	0.00127	CcSEcCtD
Acetazolamide—Urticaria—Prednisone—multiple sclerosis	0.000547	0.00125	CcSEcCtD
Acetazolamide—Headache—Triamcinolone—multiple sclerosis	0.000546	0.00125	CcSEcCtD
Acetazolamide—Headache—Methylprednisolone—multiple sclerosis	0.000545	0.00125	CcSEcCtD
Acetazolamide—Body temperature increased—Prednisone—multiple sclerosis	0.000544	0.00125	CcSEcCtD
Acetazolamide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000541	0.00124	CcSEcCtD
Acetazolamide—Diarrhoea—Betamethasone—multiple sclerosis	0.000541	0.00124	CcSEcCtD
Acetazolamide—CA3—Metabolism—GPC5—multiple sclerosis	0.000537	0.00506	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SRM—multiple sclerosis	0.000537	0.00506	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SRM—multiple sclerosis	0.000523	0.00493	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SRM—multiple sclerosis	0.000523	0.00493	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—IL6—multiple sclerosis	0.000523	0.00493	CbGpPWpGaD
Acetazolamide—Dizziness—Dexamethasone—multiple sclerosis	0.000523	0.0012	CcSEcCtD
Acetazolamide—Dizziness—Betamethasone—multiple sclerosis	0.000523	0.0012	CcSEcCtD
Acetazolamide—Nausea—Triamcinolone—multiple sclerosis	0.000518	0.00118	CcSEcCtD
Acetazolamide—Paraesthesia—Methotrexate—multiple sclerosis	0.000517	0.00118	CcSEcCtD
Acetazolamide—Nausea—Methylprednisolone—multiple sclerosis	0.000517	0.00118	CcSEcCtD
Acetazolamide—AQP1—Metabolism—RRM1—multiple sclerosis	0.000513	0.00484	CbGpPWpGaD
Acetazolamide—Somnolence—Methotrexate—multiple sclerosis	0.000512	0.00117	CcSEcCtD
Acetazolamide—Dyspepsia—Methotrexate—multiple sclerosis	0.000507	0.00116	CcSEcCtD
Acetazolamide—Vomiting—Dexamethasone—multiple sclerosis	0.000503	0.00115	CcSEcCtD
Acetazolamide—Vomiting—Betamethasone—multiple sclerosis	0.000503	0.00115	CcSEcCtD
Acetazolamide—Decreased appetite—Methotrexate—multiple sclerosis	0.0005	0.00114	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000497	0.00114	CcSEcCtD
Acetazolamide—Fatigue—Methotrexate—multiple sclerosis	0.000496	0.00114	CcSEcCtD
Acetazolamide—Headache—Betamethasone—multiple sclerosis	0.000495	0.00113	CcSEcCtD
Acetazolamide—Headache—Dexamethasone—multiple sclerosis	0.000495	0.00113	CcSEcCtD
Acetazolamide—Asthenia—Prednisone—multiple sclerosis	0.000494	0.00113	CcSEcCtD
Acetazolamide—CA7—Metabolism—SRM—multiple sclerosis	0.000488	0.0046	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SRM—multiple sclerosis	0.000488	0.0046	CbGpPWpGaD
Acetazolamide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000474	0.00109	CcSEcCtD
Acetazolamide—Diarrhoea—Prednisone—multiple sclerosis	0.000471	0.00108	CcSEcCtD
Acetazolamide—Nausea—Betamethasone—multiple sclerosis	0.00047	0.00107	CcSEcCtD
Acetazolamide—Nausea—Dexamethasone—multiple sclerosis	0.00047	0.00107	CcSEcCtD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00047	0.00443	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00047	0.00443	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000463	0.00437	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000463	0.00437	CbGpPWpGaD
Acetazolamide—Urticaria—Methotrexate—multiple sclerosis	0.000457	0.00105	CcSEcCtD
Acetazolamide—Dizziness—Prednisone—multiple sclerosis	0.000455	0.00104	CcSEcCtD
Acetazolamide—Body temperature increased—Methotrexate—multiple sclerosis	0.000455	0.00104	CcSEcCtD
Acetazolamide—CA12—Metabolism—SRM—multiple sclerosis	0.000453	0.00427	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—RRM1—multiple sclerosis	0.000445	0.00419	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—CD4—multiple sclerosis	0.000438	0.00413	CbGpPWpGaD
Acetazolamide—Vomiting—Prednisone—multiple sclerosis	0.000438	0.001	CcSEcCtD
Acetazolamide—Headache—Prednisone—multiple sclerosis	0.000432	0.000987	CcSEcCtD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000422	0.00398	CbGpPWpGaD
Acetazolamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000421	0.00397	CbGpPWpGaD
Acetazolamide—Asthenia—Methotrexate—multiple sclerosis	0.000413	0.000945	CcSEcCtD
Acetazolamide—Nausea—Prednisone—multiple sclerosis	0.000409	0.000936	CcSEcCtD
Acetazolamide—Diarrhoea—Methotrexate—multiple sclerosis	0.000394	0.000901	CcSEcCtD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000381	0.00359	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000381	0.00359	CbGpPWpGaD
Acetazolamide—Dizziness—Methotrexate—multiple sclerosis	0.000381	0.000871	CcSEcCtD
Acetazolamide—CA14—Metabolism—CYP24A1—multiple sclerosis	0.000378	0.00357	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP27B1—multiple sclerosis	0.000378	0.00357	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP27B1—multiple sclerosis	0.000369	0.00347	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP24A1—multiple sclerosis	0.000369	0.00347	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP27B1—multiple sclerosis	0.000369	0.00347	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP24A1—multiple sclerosis	0.000369	0.00347	CbGpPWpGaD
Acetazolamide—Vomiting—Methotrexate—multiple sclerosis	0.000366	0.000837	CcSEcCtD
Acetazolamide—CA4—Metabolism—SRM—multiple sclerosis	0.000361	0.0034	CbGpPWpGaD
Acetazolamide—Headache—Methotrexate—multiple sclerosis	0.000361	0.000825	CcSEcCtD
Acetazolamide—CA9—Cellular responses to stress—IFNB1—multiple sclerosis	0.000352	0.00331	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SRM—multiple sclerosis	0.000346	0.00326	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GPC5—multiple sclerosis	0.000346	0.00326	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP24A1—multiple sclerosis	0.000344	0.00324	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP27B1—multiple sclerosis	0.000344	0.00324	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP24A1—multiple sclerosis	0.000344	0.00324	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP27B1—multiple sclerosis	0.000344	0.00324	CbGpPWpGaD
Acetazolamide—Nausea—Methotrexate—multiple sclerosis	0.000342	0.000782	CcSEcCtD
Acetazolamide—CA5A—Metabolism—GPC5—multiple sclerosis	0.000337	0.00318	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GPC5—multiple sclerosis	0.000337	0.00318	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SRM—multiple sclerosis	0.000332	0.00313	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP27B1—multiple sclerosis	0.000319	0.00301	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP24A1—multiple sclerosis	0.000319	0.00301	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—MYC—multiple sclerosis	0.000315	0.00297	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GPC5—multiple sclerosis	0.000315	0.00297	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GPC5—multiple sclerosis	0.000315	0.00297	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000296	0.00279	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000295	0.00278	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—BCHE—multiple sclerosis	0.000295	0.00278	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GPC5—multiple sclerosis	0.000292	0.00275	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SRM—multiple sclerosis	0.000292	0.00275	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—RRM1—multiple sclerosis	0.000287	0.0027	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000283	0.00267	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—RRM1—multiple sclerosis	0.000279	0.00263	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—RRM1—multiple sclerosis	0.000279	0.00263	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—RRM1—multiple sclerosis	0.000261	0.00246	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—RRM1—multiple sclerosis	0.000261	0.00246	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—BCHE—multiple sclerosis	0.000256	0.00241	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP27B1—multiple sclerosis	0.000254	0.0024	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP24A1—multiple sclerosis	0.000254	0.0024	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP27B1—multiple sclerosis	0.000244	0.0023	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP24A1—multiple sclerosis	0.000244	0.0023	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000242	0.00228	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—RRM1—multiple sclerosis	0.000242	0.00228	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP27B1—multiple sclerosis	0.000234	0.0022	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP24A1—multiple sclerosis	0.000234	0.0022	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GPC5—multiple sclerosis	0.000233	0.00219	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GPC5—multiple sclerosis	0.000223	0.0021	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000215	0.00202	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GPC5—multiple sclerosis	0.000214	0.00201	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP24A1—multiple sclerosis	0.000205	0.00194	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP27B1—multiple sclerosis	0.000205	0.00194	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000202	0.00191	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000202	0.00191	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000199	0.00188	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000199	0.00188	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—RRM1—multiple sclerosis	0.000193	0.00182	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GPC5—multiple sclerosis	0.000188	0.00177	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—RRM1—multiple sclerosis	0.000185	0.00174	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—APOE—multiple sclerosis	0.000177	0.00167	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—RRM1—multiple sclerosis	0.000177	0.00167	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00017	0.0016	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—BCHE—multiple sclerosis	0.000165	0.00155	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—BCHE—multiple sclerosis	0.00016	0.00151	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—BCHE—multiple sclerosis	0.00016	0.00151	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—RRM1—multiple sclerosis	0.000156	0.00147	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—APOE—multiple sclerosis	0.000154	0.00145	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—POMC—multiple sclerosis	0.000152	0.00144	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00015	0.00141	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—BCHE—multiple sclerosis	0.00015	0.00141	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—BCHE—multiple sclerosis	0.00015	0.00141	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—ALB—multiple sclerosis	0.000139	0.00131	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—BCHE—multiple sclerosis	0.000139	0.00131	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—POMC—multiple sclerosis	0.000132	0.00124	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ALB—multiple sclerosis	0.00012	0.00113	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—STAT3—multiple sclerosis	0.000119	0.00112	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—BCHE—multiple sclerosis	0.000111	0.00104	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MAPK1—multiple sclerosis	0.000108	0.00102	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000106	0.001	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—BCHE—multiple sclerosis	0.000106	0.001	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000106	0.000996	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—BCHE—multiple sclerosis	0.000102	0.000959	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—APOE—multiple sclerosis	9.91e-05	0.000934	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—APOE—multiple sclerosis	9.65e-05	0.00091	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—APOE—multiple sclerosis	9.65e-05	0.00091	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APOE—multiple sclerosis	9.01e-05	0.000849	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APOE—multiple sclerosis	9.01e-05	0.000849	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—BCHE—multiple sclerosis	8.94e-05	0.000843	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.56e-05	0.000807	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—POMC—multiple sclerosis	8.51e-05	0.000802	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOE—multiple sclerosis	8.35e-05	0.000787	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—IL6—multiple sclerosis	8.34e-05	0.000786	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—POMC—multiple sclerosis	8.29e-05	0.000782	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—POMC—multiple sclerosis	8.29e-05	0.000782	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ALB—multiple sclerosis	7.76e-05	0.000731	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—POMC—multiple sclerosis	7.74e-05	0.00073	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—POMC—multiple sclerosis	7.74e-05	0.00073	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ALB—multiple sclerosis	7.56e-05	0.000713	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ALB—multiple sclerosis	7.56e-05	0.000713	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—POMC—multiple sclerosis	7.17e-05	0.000676	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ALB—multiple sclerosis	7.06e-05	0.000665	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ALB—multiple sclerosis	7.06e-05	0.000665	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOE—multiple sclerosis	6.66e-05	0.000628	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ALB—multiple sclerosis	6.54e-05	0.000616	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOE—multiple sclerosis	6.38e-05	0.000602	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOE—multiple sclerosis	6.12e-05	0.000577	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—POMC—multiple sclerosis	5.72e-05	0.000539	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—POMC—multiple sclerosis	5.48e-05	0.000517	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.4e-05	0.000509	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOE—multiple sclerosis	5.38e-05	0.000507	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—POMC—multiple sclerosis	5.26e-05	0.000496	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALB—multiple sclerosis	5.21e-05	0.000491	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALB—multiple sclerosis	5e-05	0.000471	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SRM—multiple sclerosis	4.91e-05	0.000463	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALB—multiple sclerosis	4.79e-05	0.000452	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—POMC—multiple sclerosis	4.62e-05	0.000436	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.55e-05	0.000429	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALB—multiple sclerosis	4.21e-05	0.000397	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.46e-05	0.000326	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.46e-05	0.000326	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.16e-05	0.000298	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.62e-05	0.000247	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.000142	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOE—multiple sclerosis	9.06e-06	8.54e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—POMC—multiple sclerosis	7.78e-06	7.33e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALB—multiple sclerosis	7.09e-06	6.69e-05	CbGpPWpGaD
